Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 CAD | +4.07% | -9.22% | +509.52% |
May. 13 | Medicenna Says ABILITY-1 Abstract Withdrawn by ASCO Program Committee | MT |
May. 13 | Medicenna Brief: Providing Update on its Presentations at the 2024 ASCO Annual Meeting | MT |
Sales 2024 * | - | Sales 2025 * | 438K 321K | Capitalization | 191M 140M |
---|---|---|---|---|---|
Net income 2024 * | -15M -11.01M | Net income 2025 * | -19M -13.94M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 438 x |
P/E ratio 2024 * |
-11.3
x | P/E ratio 2025 * |
-9.66
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.81% |
Latest transcript on Medicenna Therapeutics Corp.
1 day | +4.07% | ||
1 week | -9.22% | ||
Current month | +10.34% | ||
1 month | +30.61% | ||
3 months | +197.67% | ||
6 months | +401.96% | ||
Current year | +509.52% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11-09-30 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
David Hyman
DFI | Director of Finance/CFO | - | Feb. 13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 19-09-23 |
Albert Beraldo
BRD | Director/Board Member | - | 16-11-21 |
Fahar Merchant
CEO | Chief Executive Officer | - | 15-02-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 2.56 | +4.07% | 122,667 |
24-05-13 | 2.46 | -0.40% | 130,954 |
24-05-10 | 2.47 | -10.83% | 174,458 |
24-05-09 | 2.77 | +5.73% | 81,330 |
24-05-08 | 2.62 | -7.09% | 121,811 |
Delayed Quote Toronto S.E., May 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+509.52% | 140M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+46.62% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- MDNA Stock